Previous Announcement Regarding Appointment Of NED

RNS Number : 3957C

AstraZeneca PLC

28 September 2018

 

28 September 2018 16:00 BST

PREVIOUS ANNOUNCEMENT REGARDING APPOINTMENT OF NON-EXECUTIVE DIRECTOR

AstraZeneca PLC (the Company) today announced that with the Company's agreement, Joseph G. Peter (Joe Peter) has withdrawn his candidacy as a Non-Executive Director and a member of the Audit Committee.  His proposed appointment to these positions was announced by the Company on 6 September 2018 and was to have become effective on 1 October 2018.  Mr Peter's decision is for reasons that are not related to the Company.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca.

Media Relations
Karen Birmingham	UK/Global		[phone]
Rob Skelding	UK/Global		[phone]
Matt Kent	UK/Global		[phone]
Gonzalo Viña	UK/Global		[phone]
Jacob Lund	Sweden		[phone]
Michele Meixell	US		[phone]
Investor Relations
Thomas Kudsk Larsen			[phone]
Henry Wheeler	Oncology		[phone]
Christer Gruvris	Cardiovascular; Metabolism		[phone]
Nick Stone	Respiratory; Renal		[phone]
Josie Afolabi	Other		[phone]
Craig Marks	Finance; Fixed Income		[phone]
Jennifer Kretzmann	Retail Investors		[phone]
US toll-free			[phone]

Adrian Kemp
Company Secretary

AstraZeneca PLC

 

END

 

 

BOAZVLFLVKFLBBZ